{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T03:09:28Z","timestamp":1788318568031,"version":"build-2803163510"},"reference-count":25,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":2953,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1124\/jpet.116.236547","type":"journal-article","created":{"date-parts":[[2016,9,19]],"date-time":"2016-09-19T22:29:09Z","timestamp":1474324149000},"page":"471-481","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Abuse Potential and Pharmacodynamic Characteristics of Oral and Intranasal Eluxadoline, a Mixed \u03bc- and \u03ba-Opioid Receptor Agonist and \u03b4-Opioid Receptor Antagonist"],"prefix":"10.1016","volume":"359","author":[{"given":"N.","family":"Levy-Cooperman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"McIntyre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Bonifacio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"McDonnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.M.","family":"Davenport","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.S.","family":"Covington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.S.","family":"Dove","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.M.","family":"Sellers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.116.236547_bib1","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0022-3565(25)20227-0","article-title":"Selective blockage of delta opioid receptors prevents the development of morphine tolerance and dependence in mice","volume":"258","author":"Abdelhamid","year":"1991","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.116.236547_bib2","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/s002130000624","article-title":"Effect of intravenous injection speed on responses to cocaine and hydromorphone in humans","volume":"154","author":"Abreu","year":"2001","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.116.236547_bib3","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/npp.2010.137","article-title":"The therapeutic potential of \u03ba-opioids for treatment of pain and addiction","volume":"36","author":"Chavkin","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/jpet.116.236547_bib4","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1002\/jcph.442","article-title":"Effect of uptake transporters OAT3 and OATP1B1 and efflux transporter MRP2 on the pharmacokinetics of eluxadoline","volume":"55","author":"Davenport","year":"2015","journal-title":"J Clin Pharmacol"},{"key":"10.1124\/jpet.116.236547_bib5","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.bcp.2014.09.015","article-title":"Molecular characterization of eluxadoline as a potential ligand targeting mu-delta opioid receptor heteromers","volume":"92","author":"Fujita","year":"2014","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/jpet.116.236547_bib6","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/clpt.1980.239","article-title":"Abuse potential of loperamide","volume":"28","author":"Jaffe","year":"1980","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/jpet.116.236547_bib7","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/BF02245920","article-title":"Self-administration in baboons and the discriminative stimulus effects in rats of bupropion, nomifensine, diclofensine and imipramine","volume":"102","author":"Lamb","year":"1990","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.116.236547_bib8","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1056\/NEJMoa1505180","article-title":"Eluxadoline for irritable bowel syndrome with diarrhea","volume":"374","author":"Lembo","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1124\/jpet.116.236547_bib9","unstructured":"Perrino PJ, Colucci S, Harris S, and Sellers E (2012) Evaluation of abuse potential of crushed and intranasally administered oxycodone tablets. 74th Annual College on Problems of Drug Dependence Annual Meeting; 2012 June 9\u201314; Palm Springs, California. College on Problems of Drug Dependence Annual Meeting, Philadelphia, PA."},{"key":"10.1124\/jpet.116.236547_bib10","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S0022-3565(24)38876-7","article-title":"Effects of agonist-antagonist opioids in humans trained in a hydromorphone\/not hydromorphone discrimination","volume":"295","author":"Preston","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.116.236547_bib11","doi-asserted-by":"crossref","first-page":"6362","DOI":"10.1523\/JNEUROSCI.1205-04.2004","article-title":"The rate of cocaine administration alters gene regulation and behavioral plasticity: implications for addiction","volume":"24","author":"Samaha","year":"2004","journal-title":"J Neurosci"},{"key":"10.1124\/jpet.116.236547_bib12","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/(SICI)1097-0282(1999)51:6<411::AID-BIP4>3.0.CO;2-Z","article-title":"The TIPP opioid peptide family: development of delta antagonists, delta agonists, and mixed mu agonist\/delta antagonists","volume":"51","author":"Schiller","year":"1999","journal-title":"Biopolymers"},{"key":"10.1124\/jpet.116.236547_bib13","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1176\/ajp.155.4.470","article-title":"Site of opioid action in the human brain: mu and kappa agonists\u2019 subjective and cerebral blood flow effects","volume":"155","author":"Schlaepfer","year":"1998","journal-title":"Am J Psychiatry"},{"key":"10.1124\/jpet.116.236547_bib14","unstructured":"Sellers EM and Spivey (2009) Re-evaluation of the pharmacodynamics, pharmacokinetics, safety and tolerability of Acurox\u00ae tablets compared with oxycodone HCl tablets and oxycodone HCl powder administered intranasally to recreational opioid abusers. 25th Annual Meeting of the American Academy of Pain Management; 2009 Jan 28\u201331; Honolulu, HI. American Academy of Pain Management, Chicago, IL."},{"key":"10.1124\/jpet.116.236547_bib15","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s00213-010-1942-4","article-title":"Intravenous oxycodone, hydrocodone, and morphine in recreational opioid users: abuse potential and relative potencies","volume":"212","author":"Stoops","year":"2010","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.116.236547_bib16","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/S0022-3565(24)36624-8","article-title":"Differential regulation of dopamine transporter after chronic self-administration of bupropion and nomifensine","volume":"281","author":"Tella","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.116.236547_bib17","first-page":"69861","article-title":"Schedules of Controlled Substances: Placement of Eluxadoline Into Schedule IV. Final rule","volume":"80","year":"2015","journal-title":"Fed Regist"},{"key":"10.1124\/jpet.116.236547_bib18","first-page":"48044","article-title":"Schedules of Controlled Substances: Placement of Eluxadoline into Schedule IV. Notice of proposed rulemaking","volume":"80","year":"2015","journal-title":"Fed Regist"},{"key":"10.1124\/jpet.116.236547_bib21","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1111\/j.1476-5381.2012.02068.x","article-title":"Modulation of gastrointestinal function by MuDelta, a mixed \u03bc opioid receptor agonist\/ \u03bc opioid receptor antagonist","volume":"167","author":"Wade","year":"2012","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.116.236547_bib22","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.drugalcdep.2008.05.007","article-title":"The relative abuse liability of oral oxycodone, hydrocodone and hydromorphone assessed in prescription opioid abusers","volume":"98","author":"Walsh","year":"2008","journal-title":"Drug Alcohol Depend"},{"key":"10.1124\/jpet.116.236547_bib23","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s002130100788","article-title":"Enadoline, a selective kappa opioid agonist: comparison with butorphanol and hydromorphone in humans","volume":"157","author":"Walsh","year":"2001","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.116.236547_bib24","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s13181-012-0263-x","article-title":"Likeability and abuse liability of commonly prescribed opioids","volume":"8","author":"Wightman","year":"2012","journal-title":"J Med Toxicol"},{"key":"10.1124\/jpet.116.236547_bib25","first-page":"106","article-title":"Dependence potential of loperamide studied in rhesus monkeys","volume":"27","author":"Yanagita","year":"1979","journal-title":"NIDA Res Monogr"},{"key":"10.1124\/jpet.116.236547_bib26","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/S0022-3565(24)37712-2","article-title":"Comparing the subjective, psychomotor and physiological effects of intravenous pentazocine and morphine in normal volunteers","volume":"286","author":"Zacny","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.116.236547_bib27","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s00213-007-0937-2","article-title":"Within-subject comparison of the psychopharmacological profiles of oral oxycodone and oral morphine in non-drug-abusing volunteers","volume":"196","author":"Zacny","year":"2008","journal-title":"Psychopharmacology (Berl)"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524194542?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524194542?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.116.236547","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T12:18:34Z","timestamp":1740745114000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524194542"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S0022356524194542"],"URL":"https:\/\/doi.org\/10.1124\/jpet.116.236547","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Abuse Potential and Pharmacodynamic Characteristics of Oral and Intranasal Eluxadoline, a Mixed \u03bc- and \u03ba-Opioid Receptor Agonist and \u03b4-Opioid Receptor Antagonist","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.116.236547","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 by The Author(s)","name":"copyright","label":"Copyright"}]}}